Disseminated cryptococcosis is less common in immunocompetent individuals. Herein, we report a fatal case of cryptococcosis in apparently immunocompetent child with multiple site involvement. The yeast isolated from cerebrospinal fl uid, blood, endotracheal, gastric and lymph node aspirate was identifi ed by molecular method as Cryptococcus neoformans var. grubii.
to the global rate of viral clearance (~25%). This is the fi rst study on Egyptian viral strains that could help to elucidate some of the viral factors that may be responsible for viral clearance. This case report showed how a genotype variation in an important stem loop of the IRES can induce a direct phenotype change exemplifi ed in the clearance of the virus from the patient. Such critical sequences may be used as therapeutic targets to abolish HCV replication using RNA silencing and/or antisense RNA. Further studies on patients who cleared the infection and analysis of the IRES region is required to assert the conclusion of this report, along with experimental verifi cation of the changes in secondary structure of the IRES's subdomains. Cryptococcus was isolated on Sabouraud dextrose agar and bird seed agar. The same fungus was detected from blood, gastric aspirate, and endotracheal aspirate culture. The isolate was urease positive and there was no colour change on canavanine glycine bromothymol blue (CGB) agar (25°C for 5 days). Antifungal susceptibility testing was performed as per Clinical Laboratories Standard Institute document for broth dilution technique (M 27 A3). The minimum inhibitory concentration (MIC) of isolate was: Amphotericin B-0.25 g/ml; fl uconazole-1.0 g/ml; itraconazole-0.03 g/ml; voriconazole-0.03 g/ml; caspofungin-2.0 g/ml; anidulafungin-2.0 g/ml; micafungin-2.0 g/ml.
The growth of Cryptococcus was used to extract the deoxyribose nucleic acid (DNA) and was amplifi ed using ITS 1, 4 and 26S rRNA primers. It was then subjected to sequencing by Big Dye Terminator Cycle Sequencing Kit, Version 3.1 (Applied Biosystems, Foster city, CA, USA) and analysed by ABI 3130 Genetic Analyser (Applied Biosystems). [5] The sequence obtained was compared with GenBank DNA database. The strain showed 100% similarity with standard strain of Cryptococcus neoformans var. grubii (CBS 8710, GenBank accession FJ534879). The isolate was deposited at the National Culture Collection of Pathogenic Fungi (NCCPF), Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India with accession NCCPF 250472. The nucleotide sequence is deposited in GenBank with accession KJ777814.
Urine sample showed growth of Escherichia coli. Acid-fast stain for gastric aspirate, sputum and lymph node aspirate were negative.
Initially, anti-tubercular therapy (ATT) was given for three days as the symptoms were quite suggestive of tuberculosis. However, after FNAC for lymph node demonstrated Cryptococcus, patient was started on liposomal amphotericin B (6 mg/kg/day) and 5 fl ucytosine (100 mg/kg/day in four divided doses). Two days later, liposomal formulation was replaced by conventional amphotericin B (1 mg/kg/day), which led to the development of hypokalaemia, for which she was given potassium supplements. She was given mannitol, 3% hypertonic saline, and glycerol for decreasing
Introduction
Cryptococcus is encapsulated yeast, which is present in environment, especially in soil contaminated with bird excreta. Predominantly, it affects the immunocompromised individuals, especially those infected by human immunodefi ciency virus (HIV). The infections of pulmonary and central nervous system (CSI) are the most common among the infections caused by this agent. [1] However, disseminated infection can occur in immunosuppressed patients. Such disseminated infection is rarely reported in immunocompetent children. [2] [3] [4] [5] [6] Herein, we present the fi rst case from India, of an immunocompetent female child, who died due to disseminated infection by Cryptococcus neoformans var grubii.
Case Report
An 11-year-old female child, resident of Jammu and Kashmir presented with 2 months history of intermittent pain in epigastrium and right hypochondrium and intermittent fever documented up to 102°F associated with vomiting. She had jaundice since 1 month with dark coloured urine, loss of weight and appetite. She was admitted in local hospital for these symptoms but no improvement was seen. When she was presented to our hospital, she had headache in addition to recurrent vomiting since 2 days and had diminished response to stimuli for 1 day. She had raised intracranial pressure and had an episode of seizures with up rolling of eyes. She had no history of pruritis, bleeding from any site, focal neurological defi cit or any change in behaviour or trauma, with no history of diabetes mellitus, tuberculosis, malignancy or chronic illness. Her family did not give any history of exposure to bird excreta.
Clinical examination revealed icterus and pallor along with lymphadenopathy. Liver was enlarged with presence of distended veins over the abdomen. Kernig's sign was positive and the fundus showed papilloedema. She had altered sensorium with Glasgow Coma Score (GCS) E2 M4 V2.
Laboratory investigations showed haemoglobin of 7.7 gm, total leucocyte count (TLC) of 18,000 with predominant neutrophils. Other fi ndings included hyperglycaemia, hypokalaemia, hypernatraemia and azotaemia. She was non reactive for HIV. Investigations for cell-mediated, humoural and phagocytic immunity did not show any evidence of immunodefi ciency.
Ultrasonography (USG) revealed multiple, enlarged lymph nodes at portal, peri-pancreatic regions and intracranial tension. She also developed hyperglycaemia (central diabetes insipidus) and was started on insulin and vasopressin therapy. Phenytoin (5 mg/kg/day) was given for epileptic seizure. She went into shock with persistent fever spikes and intermittent episodes of hyperventilation and was started on dopamine. She was also given antibiotics including vancomycin and meropenem. She progressed to ventricular tachycardia, multiorgan dysfunction syndrome, pulmonary haemorrhage and fi nally refractory septic shock, after which she could not be revived.
Discussion
Cryptococcus neoformans causes infection most commonly in immunocompromised patients including HIV positive, solid organ transplant and haematology malignancy. [7] Disseminated infection is defi ned by a positive culture from at least two different sites or a positive blood culture. [8] In the present case, positive cultures have been obtained from multiple sites (CSF, endotracheal aspirate, gastric aspirate, and lymph node aspirate) and from blood (cryptococcaemia) as well. Cirrhosis and liver disease have been found to be an important risk factors for disseminated infection. [8, 9] In this case as well, liver involvement was present as shown by jaundice and dark-coloured urine. However, liver disease could not be investigated. The most commonly infected organ system in disseminated disease is central nervous system (CNS) followed by lung. This child had involvement of both CNS and lung.
In this case, the presentation of the disease was insidious and chronic, as the child had complaints of vomiting and headache since two months. [5] Though amphotericin B and 5 fl ucytosine were started immediately after diagnosis, it was too late as the infection had spread to multiple organs. Cryptococcosis in non-HIV patients has high mortality, possibly due to low suspicion of infection and delay in diagnosis. [1] Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. grubii cause infection generally in immunocompromised individuals, whereas Cryptococcus gattii is responsible for disease in immunocompetent hosts. [10] Disseminated infection in immunocompetent children in earlier reports was caused by Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. humicolus, both of which showed remission after treatment. [3, 4] In the present case, the isolate was identifi ed to be C. neoformans var. grubii, which has been rarely reported to cause disseminated infection in immunocompetent hosts, especially children. [5] The present case highlights the importance of suspecting this aetiologic agent in immunocompetent children with liver failure presenting with complaints that are similar to this case. The major challenge in such cases is the differential diagnosis of tuberculosis, which produces similar symptoms. It is very important to initiate treatment after prompt diagnosis is made, so as to reduce mortality due to disseminated cryptococcosis in immunocompetent hosts, especially children.
